Blood-collection startup Tasso said it has completed a $6.1 million financing round led by Vertical Venture Partners (VVP), with participation from Techstars and Cedars-Sinai. The funding will help Tasso scale its first product, Tasso OnDemand, which enables self-collection of blood samples, and to add personnel to support commercial growth.
Tasso OnDemand allows people to collect blood at home and mail the samples to the laboratory for analysis. The Seattle-based company said its inaugural product may transform how patients engage with blood testing, optimizing drug efficacy, safety, and adherence, as well as enabling frequent data on vital blood markers for drug development and care management.
At DeviceTalks Boston, Tyler Shultz will give attendees an inside look at Theranos and how he was able to sound the alarm after he realized the company was falling apart. Shultz will take attendees behind the story that everyone is talking about: the rise and fall of Elizabeth Holmes and her diagnostic company, Theranos.
Join Shultz and 1,000+ medical device professionals at the 8th annual DeviceTalks Boston.